Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kesuting syrup is an orally administered, registered Chinese herbal medicine manufactured by Guizhou Bailing for cough and respiratory symptoms associated with common cold and chronic bronchitis. It is a chemically heterogeneous nine-herb formula containing Reineckea carnea, Solomonseal rhizome, Disporum cantoniense, Platycodon root, Saxifraga stolonifera, loquat leaf, ephedra herb, mulberry root bark, and poppy capsule. Its labeled traditional use is to relieve cough, sputum production, dry throat, and wheezing; no single molecular target or clinically established target-specific mechanism has been defined. It was also evaluated in randomized clinical studies for symptomatic treatment of mild COVID-19. ([onlinelibrary.wiley.com](https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctm2.1569))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kesuting syrup.